LLY · News · 20260901N

Zepbound Coverage Evidence

ELI LILLY & Co · 2026-09-01 · Importance 23 · Surprise 24

A Lilly-run study reported that patients older than 55 taking Zepbound incurred lower healthcare costs than comparable patients not taking Zepbound. The findings could support Lilly’s efforts to obtain broader insurance coverage for Zepbound. The report did not disclose a dollar amount or timeframe for the healthcare-cost difference.

Key facts

• A study run by Eli Lilly suggests that patients older than 55 on Zepbound incur lower healthcare costs than those not on Zepbound. source